We analyzed public datasets, finding a high expression level of both HK2 and MMP-1/2/9/13/14 in benign PNs of NF1 patients (Figure 3F), disclosing the possibility of starting treatments with HK2peps before these tumors switch to the malignant phenotype. The gene discussed is MMP1; the disease is neurofibromatosis type 1.